Calmark Sweden AB Investors
Calmark Sweden AB has developed a simple method of measuring the enzyme, lactate dehydrogenase (LDH) by blood analysis. Calmark develops clinical relevant point of care biomarkers tests for new born, using a colorimetric method. Products are under development, more information coming.
Headquarters:
Karlstad, Varmlands Lan, Sweden
Industry:
Other
Investor Type:
Healthcare Company
Technology:
Other
Employee Number:
1-10
Founded Date:
2007